Population
Skeletal myosin subfragment 1 (S1)
Comparison
Fluorescent ribose-modified nucleotides with… vs Reversibly bound S1-nucleotide complexes
Design
Preclinical
Authors
Loading...
Offers no immediate clinical implications for myosin-targeted therapies; leaves open conformational dynamics in cardiac myosin models.
Trapping of skeletal myosin subfragment 1 by pPDM or vanadate induces a conformational change near the ribose binding site that relieves static quenching of fluorescent nucleotide analogues.
Cremo et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: